Microbiology News

Stealth pig cells may hold the key to treating diabetes in humans

harry shroederUniversity of Alabama at Birmingham researchers are exploring ways to wrap pig tissue with a protective coating to ultimately fight diabetes in humans. The nano-thin bilayers of protective material are meant to deter or prevent immune rejection.

The ultimate goal: transplant insulin-producing cell-clusters from pigs into humans to treat Type 1 diabetes.
Read more ...

UAB Biomarker beats gold standard in detecting brain shunt infections

harry shroederIn a study of children with brain shunts at Children’s of Alabama, a University of Alabama at Birmingham investigational biomarker outperformed the current “gold standard” test for detecting bacterial infections in the shunts.
Read more ...

Micro researchers involved in studies reporting a new quality-control checkpoint in developing B cells that may affect vaccine responses.

harry shroederMicro researchers involved in studies reporting a new quality-control checkpoint in developing B cells that may affect vaccine responses.




Checkpoint in B cell development discovered with possible implications on vaccine potency

Teaching metabolomics: a UAB outreach to researchers in sub-Saharan Africa


Janusz Kabarowski, Ph.D, is playing an important role in a metabolomics initiative.


Read more ...

Calendar

Join Our Mailing List!


If you would like to receive updates for the Micro Seminar Series, please enter your email in the field below:

Invalid Input

Travel Awards: Apply by March 15, 2013 for travel awards between UAB and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) in Durban, South Africa. Faculty, post-doctorates or senior students at both UAB and K-RITH with research interests related to tuberculosis and HIV/AIDS, including prevention sciences, are eligible to apply.

Pilot Project Awards: Apply by August 1, 2013 for Pilot Project Awards to develop collaborative projects between the University of Alabama at Birmingham (UAB) and the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) in Durban, South Africa. Faculty (at all levels) with research interests aligned with K-RITH investigators in the fields of tuberculosis or HIV/AIDS, including prevention sciences, are encouraged to apply.

Full instructions are available at the Infectious Diseases, Global Health and Vaccines Strategic Initiative website.